Establishment and Maintenance of Gammaherpesvirus Latency Are Independent of Infective Dose and Route of Infection
- 1 July 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (13) , 7696-7701
Abstract
Gammaherpesviruses such as Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus are important human pathogens that establish long-term latent infections. Understanding of the initiation and maintenance of latent infections has important implications for the prevention and treatment of gammaherpesvirus-related diseases. Although much is known about gammaherpesvirus pathogenesis, it is unclear how the infectious dose of a virus influences its ability to establish latent infection. To examine the relationship between the infectious dose and gammaherpesvirus latency, we inoculated wild-type mice with 0.01 to 10 6 PFU of murine gammaherpesvirus 68 (γHV68) and quantitatively measured latency and acute-phase replication. Surprisingly, during latency, the frequencies of ex vivo reactivation were similar over a 10 7 -fold range of doses for i.p. infection and over a 10 4 -fold range of doses for intranasal infection. Further, the frequencies of cells harboring viral genome during latency did not differ substantially over similar dose ranges. Although the kinetics of acute-phase replication were delayed at small doses of virus, the peak titer did not differ significantly between mice infected with a large dose of virus and those infected with a small dose of virus. The results presented here indicate that any initiation of infection leads to substantial acute-phase replication and subsequent establishment of a maximal level of latency. Thus, infections with doses as small as 0.1 PFU of γHV68 result in stable levels of acute-phase replication and latent infection. These results demonstrate that the equilibrium level of establishment of gammaherpesvirus latency is independent of the infectious dose and route of infection.Keywords
This publication has 30 references indexed in Scilit:
- Effective Vaccination against Long-Term Gammaherpesvirus LatencyJournal of Virology, 2003
- The wood mouse is a natural host for Murid herpesvirus 4Journal of General Virology, 2003
- Antibody to a Lytic Cycle Viral Protein Decreases Gammaherpesvirus Latency in B-Cell-Deficient MiceJournal of Virology, 2002
- Immune Control of the Number and Reactivation Phenotype of Cells Latently Infected with a GammaherpesvirusJournal of Virology, 2002
- Identification of the In Vivo Role of a Viral bcl-2Journal of Experimental Medicine, 2002
- Disruption of the M2 Gene of Murine Gammaherpesvirus 68 Alters Splenic Latency following Intranasal, but Not Intraperitoneal, InoculationJournal of Virology, 2002
- Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: A model system for gamma-herpesvirus vaccinationVaccine, 1999
- Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cellsJournal of General Virology, 1996
- Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivoJournal of General Virology, 1992
- Virological and pathological features of mice infected with murine gammaherpesvirus 68Journal of General Virology, 1992